Futura Medical plc
FUM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £13,926 | £3,101 | £0 | £0 |
| % Growth | 349.1% | – | – | – |
| Cost of Goods Sold | £4,237 | £1,327 | £25 | £20 |
| Gross Profit | £9,568 | £1,774 | -£25 | -£20 |
| % Margin | 68.7% | 57.2% | – | – |
| R&D Expenses | £1,742 | £2,046 | £4,131 | £3,774 |
| G&A Expenses | £6,831 | £6,692 | £2,740 | £2,092 |
| SG&A Expenses | £6,650 | £6,692 | £2,740 | £2,092 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £8,392 | £8,738 | £6,871 | £5,866 |
| Operating Income | £1,176 | -£6,964 | -£6,871 | -£5,866 |
| % Margin | 8.4% | -224.6% | – | – |
| Other Income/Exp. Net | £115 | £72 | £0 | £40 |
| Pre-Tax Income | £1,291 | -£6,892 | -£6,871 | -£5,866 |
| Tax Expense | -£2 | -£379 | -£1,025 | -£909 |
| Net Income | £1,293 | -£6,513 | -£5,846 | -£4,958 |
| % Margin | 9.3% | -210% | – | – |
| EPS | 0.004 | -0.022 | -0.02 | -0.018 |
| % Growth | 119.9% | -6.4% | -10.9% | – |
| EPS Diluted | 0.004 | -0.022 | -0.02 | -0.018 |
| Weighted Avg Shares Out | 302,118 | 301,406 | 287,478 | 271,046 |
| Weighted Avg Shares Out Dil | 310,768 | 301,406 | 287,478 | 271,046 |
| Supplemental Information | – | – | – | – |
| Interest Income | £47 | £72 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £122 | £130 | £25 | £20 |
| EBITDA | £1,413 | -£6,833 | -£6,847 | -£5,847 |
| % Margin | 10.1% | -220.4% | – | – |